Logo image of FRE.DE

FRESENIUS SE & CO KGAA (FRE.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:FRE - DE0005785604 - Common Stock

47.56 EUR
-0.35 (-0.73%)
Last: 12/12/2025, 7:00:00 PM
Fundamental Rating

4

FRE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 29 industry peers in the Health Care Providers & Services industry. FRE has only an average score on both its financial health and profitability. FRE has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

FRE had positive earnings in the past year.
In the past year FRE had a positive cash flow from operations.
Of the past 5 years FRE 4 years were profitable.
FRE had a positive operating cash flow in each of the past 5 years.
FRE.DE Yearly Net Income VS EBIT VS OCF VS FCFFRE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

Looking at the Return On Assets, with a value of 2.69%, FRE is in line with its industry, outperforming 55.17% of the companies in the same industry.
Looking at the Return On Equity, with a value of 6.14%, FRE is in line with its industry, outperforming 41.38% of the companies in the same industry.
The Return On Invested Capital of FRE (3.26%) is worse than 68.97% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for FRE is below the industry average of 6.67%.
The 3 year average ROIC (1.83%) for FRE is below the current ROIC(3.26%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.69%
ROE 6.14%
ROIC 3.26%
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
FRE.DE Yearly ROA, ROE, ROICFRE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

Looking at the Profit Margin, with a value of 5.11%, FRE belongs to the top of the industry, outperforming 93.10% of the companies in the same industry.
In the last couple of years the Profit Margin of FRE has declined.
FRE's Operating Margin of 9.76% is amongst the best of the industry. FRE outperforms 89.66% of its industry peers.
FRE's Operating Margin has declined in the last couple of years.
FRE's Gross Margin of 24.99% is in line compared to the rest of the industry. FRE outperforms 51.72% of its industry peers.
FRE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.76%
PM (TTM) 5.11%
GM 24.99%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
FRE.DE Yearly Profit, Operating, Gross MarginsFRE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FRE is destroying value.
FRE has about the same amout of shares outstanding than it did 1 year ago.
FRE has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, FRE has an improved debt to assets ratio.
FRE.DE Yearly Shares OutstandingFRE.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
FRE.DE Yearly Total Debt VS Total AssetsFRE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

FRE has an Altman-Z score of 2.06. This is not the best score and indicates that FRE is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of FRE (2.06) is comparable to the rest of the industry.
FRE has a debt to FCF ratio of 11.28. This is a negative value and a sign of low solvency as FRE would need 11.28 years to pay back of all of its debts.
With a Debt to FCF ratio value of 11.28, FRE is not doing good in the industry: 62.07% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.61 indicates that FRE is somewhat dependend on debt financing.
FRE has a Debt to Equity ratio of 0.61. This is amongst the best in the industry. FRE outperforms 82.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 11.28
Altman-Z 2.06
ROIC/WACC0.63
WACC5.2%
FRE.DE Yearly LT Debt VS Equity VS FCFFRE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

FRE has a Current Ratio of 1.26. This is a normal value and indicates that FRE is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of FRE (1.26) is better than 65.52% of its industry peers.
A Quick Ratio of 0.99 indicates that FRE may have some problems paying its short term obligations.
The Quick ratio of FRE (0.99) is better than 62.07% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.99
FRE.DE Yearly Current Assets VS Current LiabilitesFRE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

FRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 215.74%, which is quite impressive.
FRE shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.29% yearly.
The Revenue has been growing slightly by 2.13% in the past year.
FRE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.22% yearly.
EPS 1Y (TTM)215.74%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%20.29%
Revenue 1Y (TTM)2.13%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%2.22%

3.2 Future

Based on estimates for the next years, FRE will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.63% on average per year.
The Revenue is expected to grow by 4.90% on average over the next years.
EPS Next Y13.2%
EPS Next 2Y12.64%
EPS Next 3Y11.7%
EPS Next 5Y10.63%
Revenue Next Year4.46%
Revenue Next 2Y4.83%
Revenue Next 3Y4.85%
Revenue Next 5Y4.9%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FRE.DE Yearly Revenue VS EstimatesFRE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B
FRE.DE Yearly EPS VS EstimatesFRE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.95 indicates a correct valuation of FRE.
FRE's Price/Earnings ratio is a bit cheaper when compared to the industry. FRE is cheaper than 79.31% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.54. FRE is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 12.45, which indicates a correct valuation of FRE.
68.97% of the companies in the same industry are more expensive than FRE, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.78, FRE is valued a bit cheaper.
Industry RankSector Rank
PE 13.95
Fwd PE 12.45
FRE.DE Price Earnings VS Forward Price EarningsFRE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

FRE's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, FRE is valued a bit more expensive than the industry average as 75.86% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 22.34
EV/EBITDA 10.38
FRE.DE Per share dataFRE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

FRE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.06
PEG (5Y)N/A
EPS Next 2Y12.64%
EPS Next 3Y11.7%

3

5. Dividend

5.1 Amount

FRE has a Yearly Dividend Yield of 2.09%.
Compared to an average industry Dividend Yield of 1.92, FRE pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 1.96, FRE has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.09%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
FRE.DE Yearly Dividends per shareFRE.DE Yearly Dividends per shareYearly Dividends per share 2015 2016 2019 2020 2021 2022 2023 2025 0.5 1 1.5

5.3 Sustainability

FRE pays out 59.84% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP59.84%
EPS Next 2Y12.64%
EPS Next 3Y11.7%
FRE.DE Yearly Income VS Free CF VS DividendFRE.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B
FRE.DE Dividend Payout.FRE.DE Dividend Payout, showing the Payout Ratio.FRE.DE Dividend Payout.PayoutRetained Earnings

FRESENIUS SE & CO KGAA

FRA:FRE (12/12/2025, 7:00:00 PM)

47.56

-0.35 (-0.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)03-25 2026-03-25/amc
Inst Owners46.81%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap26.79B
Revenue(TTM)22.35B
Net Income(TTM)1.14B
Analysts86.09
Price Target55.24 (16.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.09%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP59.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.22%
Min EPS beat(2)8.91%
Max EPS beat(2)13.53%
EPS beat(4)4
Avg EPS beat(4)13.17%
Min EPS beat(4)8.91%
Max EPS beat(4)17.61%
EPS beat(8)5
Avg EPS beat(8)-25.39%
EPS beat(12)7
Avg EPS beat(12)-39.44%
EPS beat(16)8
Avg EPS beat(16)-31.03%
Revenue beat(2)1
Avg Revenue beat(2)-1.68%
Min Revenue beat(2)-4.68%
Max Revenue beat(2)1.31%
Revenue beat(4)3
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-4.68%
Max Revenue beat(4)2.84%
Revenue beat(8)4
Avg Revenue beat(8)-0.27%
Revenue beat(12)4
Avg Revenue beat(12)-0.51%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)5.66%
PT rev (3m)9.61%
EPS NQ rev (1m)-13.24%
EPS NQ rev (3m)-11.29%
EPS NY rev (1m)-0.2%
EPS NY rev (3m)2.8%
Revenue NQ rev (1m)-0.45%
Revenue NQ rev (3m)0.18%
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-0.29%
Valuation
Industry RankSector Rank
PE 13.95
Fwd PE 12.45
P/S 1.2
P/FCF 22.34
P/OCF 12.3
P/B 1.44
P/tB 14.46
EV/EBITDA 10.38
EPS(TTM)3.41
EY7.17%
EPS(NY)3.82
Fwd EY8.03%
FCF(TTM)2.13
FCFY4.48%
OCF(TTM)3.87
OCFY8.13%
SpS39.68
BVpS33.06
TBVpS3.29
PEG (NY)1.06
PEG (5Y)N/A
Graham Number50.37
Profitability
Industry RankSector Rank
ROA 2.69%
ROE 6.14%
ROCE 6.63%
ROIC 3.26%
ROICexc 3.7%
ROICexgc 8.63%
OM 9.76%
PM (TTM) 5.11%
GM 24.99%
FCFM 5.37%
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
ROICexc(3y)1.84%
ROICexc(5y)2.65%
ROICexgc(3y)3.69%
ROICexgc(5y)5.83%
ROCE(3y)3.71%
ROCE(5y)5.33%
ROICexgc growth 3Y-17.75%
ROICexgc growth 5Y-15.4%
ROICexc growth 3Y-12.52%
ROICexc growth 5Y-11.09%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
F-Score7
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 11.28
Debt/EBITDA 3.4
Cap/Depr 86.4%
Cap/Sales 4.38%
Interest Coverage 6.84
Cash Conversion 65.69%
Profit Quality 104.9%
Current Ratio 1.26
Quick Ratio 0.99
Altman-Z 2.06
F-Score7
WACC5.2%
ROIC/WACC0.63
Cap/Depr(3y)72.62%
Cap/Depr(5y)76.65%
Cap/Sales(3y)6.17%
Cap/Sales(5y)6.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)215.74%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%20.29%
EPS Next Y13.2%
EPS Next 2Y12.64%
EPS Next 3Y11.7%
EPS Next 5Y10.63%
Revenue 1Y (TTM)2.13%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%2.22%
Revenue Next Year4.46%
Revenue Next 2Y4.83%
Revenue Next 3Y4.85%
Revenue Next 5Y4.9%
EBIT growth 1Y51.21%
EBIT growth 3Y-24.73%
EBIT growth 5Y-17.37%
EBIT Next Year66%
EBIT Next 3Y24.43%
EBIT Next 5Y15.57%
FCF growth 1Y-61.64%
FCF growth 3Y-21.04%
FCF growth 5Y-3.73%
OCF growth 1Y-52.6%
OCF growth 3Y-21.94%
OCF growth 5Y-10.74%

FRESENIUS SE & CO KGAA / FRE.DE FAQ

What is the ChartMill fundamental rating of FRESENIUS SE & CO KGAA (FRE.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to FRE.DE.


What is the valuation status of FRESENIUS SE & CO KGAA (FRE.DE) stock?

ChartMill assigns a valuation rating of 4 / 10 to FRESENIUS SE & CO KGAA (FRE.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for FRESENIUS SE & CO KGAA?

FRESENIUS SE & CO KGAA (FRE.DE) has a profitability rating of 5 / 10.


Can you provide the financial health for FRE stock?

The financial health rating of FRESENIUS SE & CO KGAA (FRE.DE) is 4 / 10.


Can you provide the dividend sustainability for FRE stock?

The dividend rating of FRESENIUS SE & CO KGAA (FRE.DE) is 3 / 10 and the dividend payout ratio is 59.84%.